Vericel (VCEL) Other Non-Current Assets (2019 - 2026)

Vericel (VCEL) reported Other Non-Current Assets of $288000.0 for Q1 2026, down 42.51% on a YoY basis from $501000.0 in Q1 2025, and down 15.54% sequentially from $341000.0 in Q4 2025.

Vericel (VCEL) Other Non-Current Assets (2019 - 2026) Analysis & Trends

Vericel (VCEL) has 8 years of Other Non-Current Assets data on file, last reported at $288000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Other Non-Current Assets fell 42.51% year-over-year to $288000.0; the trailing twelve-month figure through Mar 2026 stood at $288000.0 (down 42.51% YoY), and the FY2025 full-year result was $341000.0, down 38.67% from the prior year.
  • Other Non-Current Assets fell to $288000.0 in Q1 2026, from $341000.0 in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $1.4 million in Q3 2022 to a low of $288000.0 in Q1 2026.
  • A 5-year average of $715941.2 and a median of $610000.0 in 2024 frame the typical range for Other Non-Current Assets.
  • Across the five-year window, Other Non-Current Assets jumped 543.13% in 2022 and tumbled 46.58% in 2024, its largest moves.
  • Tracing VCEL's Other Non-Current Assets over 5 years: stood at $1.3 million in 2022, then sank by 40.83% to $771000.0 in 2023, then retreated by 27.89% to $556000.0 in 2024, then tumbled by 38.67% to $341000.0 in 2025, then retreated by 15.54% to $288000.0 in 2026.
  • Business Quant data shows VCEL's Other Non-Current Assets at $288000.0 in Q1 2026, $341000.0 in Q4 2025, and $395000.0 in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - 1.02 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 104.24 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.26 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 2.13 Bn
7 Belite Bio 62.51 Bn 62.51 Bn - 289.41 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 124.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - 14.48 Mn
10 Vericel 2.30 Bn 2.15 Bn 49.27 Mn 288,000.00

Historic Data

Download Data
DateValue
Mar 31, 2026 288,000.00
Dec 31, 2025 341,000.00
Sep 30, 2025 395,000.00
Jun 30, 2025 447,000.00
Mar 31, 2025 501,000.00
Dec 31, 2024 556,000.00
Sep 30, 2024 610,000.00
Jun 30, 2024 664,000.00
Mar 31, 2024 717,000.00
Dec 31, 2023 771,000.00
Sep 30, 2023 1.14 Mn
Jun 30, 2023 1.20 Mn
Mar 31, 2023 1.25 Mn
Dec 31, 2022 1.30 Mn
Sep 30, 2022 1.36 Mn
Jun 30, 2022 317,000.00
Mar 31, 2022 317,000.00
Dec 31, 2021 211,000.00
Sep 30, 2021 211,000.00
Jun 30, 2021 211,000.00